269 related articles for article (PubMed ID: 23392204)
1. Neuroimaging and biochemical markers in the three variants of primary progressive aphasia.
Gil-Navarro S; Lladó A; Rami L; Castellví M; Bosch B; Bargalló N; Lomeña F; Reñé R; Montagut N; Antonell A; Molinuevo JL; Sánchez-Valle R
Dement Geriatr Cogn Disord; 2013; 35(1-2):106-17. PubMed ID: 23392204
[TBL] [Abstract][Full Text] [Related]
2. Differential chemokine alteration in the variants of primary progressive aphasia-a role for neuroinflammation.
Sogorb-Esteve A; Swift IJ; Woollacott IOC; Warren JD; Zetterberg H; Rohrer JD
J Neuroinflammation; 2021 Oct; 18(1):224. PubMed ID: 34602080
[TBL] [Abstract][Full Text] [Related]
3. Primary Progressive Aphasia Associated With
Saracino D; Ferrieux S; Noguès-Lassiaille M; Houot M; Funkiewiez A; Sellami L; Deramecourt V; Pasquier F; Couratier P; Pariente J; Géraudie A; Epelbaum S; Wallon D; Hannequin D; Martinaud O; Clot F; Camuzat A; Bottani S; Rinaldi D; Auriacombe S; Sarazin M; Didic M; Boutoleau-Bretonnière C; Thauvin-Robinet C; Lagarde J; Roué-Jagot C; Sellal F; Gabelle A; Etcharry-Bouyx F; Morin A; Coppola C; Levy R; Dubois B; Brice A; Colliot O; Gorno-Tempini ML; Teichmann M; Migliaccio R; Le Ber I;
Neurology; 2021 Jul; 97(1):e88-e102. PubMed ID: 33980708
[TBL] [Abstract][Full Text] [Related]
4. Neurofilament as a blood marker for diagnosis and monitoring of primary progressive aphasias.
Steinacker P; Semler E; Anderl-Straub S; Diehl-Schmid J; Schroeter ML; Uttner I; Foerstl H; Landwehrmeyer B; von Arnim CA; Kassubek J; Oeckl P; Huppertz HJ; Fassbender K; Fliessbach K; Prudlo J; Roßmeier C; Kornhuber J; Schneider A; Volk AE; Lauer M; Danek A; Ludolph AC; Otto M;
Neurology; 2017 Mar; 88(10):961-969. PubMed ID: 28179468
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneous Language Profiles in Patients with Primary Progressive Aphasia due to Alzheimer's Disease.
Louwersheimer E; Keulen MA; Steenwijk MD; Wattjes MP; Jiskoot LC; Vrenken H; Teunissen CE; van Berckel BN; van der Flier WM; Scheltens P; van Swieten JC; Pijnenburg YA
J Alzheimers Dis; 2016; 51(2):581-90. PubMed ID: 26890751
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of amyloid-β pathology in distinct variants of primary progressive aphasia.
Bergeron D; Gorno-Tempini ML; Rabinovici GD; Santos-Santos MA; Seeley W; Miller BL; Pijnenburg Y; Keulen MA; Groot C; van Berckel BNM; van der Flier WM; Scheltens P; Rohrer JD; Warren JD; Schott JM; Fox NC; Sanchez-Valle R; Grau-Rivera O; Gelpi E; Seelaar H; Papma JM; van Swieten JC; Hodges JR; Leyton CE; Piguet O; Rogalski EJ; Mesulam MM; Koric L; Kristensen N; Pariente J; Dickerson B; Mackenzie IR; Hsiung GR; Belliard S; Irwin DJ; Wolk DA; Grossman M; Jones M; Harris J; Mann D; Snowden JS; Chrem-Mendez P; Calandri IL; Amengual AA; Miguet-Alfonsi C; Magnin E; Magnani G; Santangelo R; Deramecourt V; Pasquier F; Mattsson N; Nilsson C; Hansson O; Keith J; Masellis M; Black SE; Matías-Guiu JA; Cabrera-Martin MN; Paquet C; Dumurgier J; Teichmann M; Sarazin M; Bottlaender M; Dubois B; Rowe CC; Villemagne VL; Vandenberghe R; Granadillo E; Teng E; Mendez M; Meyer PT; Frings L; Lleó A; Blesa R; Fortea J; Seo SW; Diehl-Schmid J; Grimmer T; Frederiksen KS; Sánchez-Juan P; Chételat G; Jansen W; Bouchard RW; Laforce RJ; Visser PJ; Ossenkoppele R
Ann Neurol; 2018 Nov; 84(5):729-740. PubMed ID: 30255971
[TBL] [Abstract][Full Text] [Related]
7. Linguistic profiles, brain metabolic patterns and rates of amyloid-β biomarker positivity in patients with mixed primary progressive aphasia.
Mazzeo S; Polito C; Padiglioni S; Berti V; Bagnoli S; Lombardi G; Piaceri I; Carraro M; De Cristofaro MT; Passeri A; Ferrari C; Nacmias B; Sorbi S; Bessi V
Neurobiol Aging; 2020 Dec; 96():155-164. PubMed ID: 33010672
[TBL] [Abstract][Full Text] [Related]
8. Decreased striatal dopamine transporter uptake in the non-fluent/agrammatic variant of primary progressive aphasia.
Gil-Navarro S; Lomeña F; Cot A; Lladó A; Montagut N; Castellví M; Bosch B; Rami L; Antonell A; Balasa M; Pavia J; Iranzo A; Molinuevo JL; Sánchez-Valle R
Eur J Neurol; 2013 Nov; 20(11):1459-e126. PubMed ID: 23679075
[TBL] [Abstract][Full Text] [Related]
9. CSF levels of Aβ1-38/Aβ1-40/Aβ1-42 and (11)C PiB-PET studies in three clinical variants of primary progressive aphasia and Alzheimer's disease.
Ikeda M; Tashiro Y; Takai E; Kurose S; Fugami N; Tsuda K; Arisaka Y; Kodaira S; Fujita Y; Makioka K; Mizuno Y; Shimada H; Harigaya Y; Takatama M; Amari M; Yamazaki T; Yamaguchi H; Higuchi T; Okamoto K; Tsushima Y; Ikeda Y
Amyloid; 2014 Dec; 21(4):238-45. PubMed ID: 25139672
[TBL] [Abstract][Full Text] [Related]
10. Amyloid pet in primary progressive aphasia: case series and systematic review of the literature.
Villarejo-Galende A; Llamas-Velasco S; Gómez-Grande A; Puertas-Martín V; Contador I; Sarandeses P; González-Sánchez M; Trincado R; Pilkington P; Ruiz-Solis S; Pérez-Martínez DA; Herrero-San Martín A
J Neurol; 2017 Jan; 264(1):121-130. PubMed ID: 27815682
[TBL] [Abstract][Full Text] [Related]
11. Is descriptive writing useful in the differential diagnosis of logopenic variant of primary progressive aphasia, Alzheimer's disease and mild cognitive impairment?
Sitek EJ; Barczak A; Kluj-Kozłowska K; Kozłowski M; Barcikowska M; Sławek J
Neurol Neurochir Pol; 2015; 49(4):239-44. PubMed ID: 26188940
[TBL] [Abstract][Full Text] [Related]
12. Deciphering logopenic primary progressive aphasia: a clinical, imaging and biomarker investigation.
Teichmann M; Kas A; Boutet C; Ferrieux S; Nogues M; Samri D; Rogan C; Dormont D; Dubois B; Migliaccio R
Brain; 2013 Nov; 136(Pt 11):3474-88. PubMed ID: 24108322
[TBL] [Abstract][Full Text] [Related]
13. A Meta-Analysis of Neuropsychological Functioning in the Logopenic Variant of Primary Progressive Aphasia: Comparison with the Semantic and Non-Fluent Variants.
Kamath V; Sutherland ER; Chaney GA
J Int Neuropsychol Soc; 2020 Mar; 26(3):322-330. PubMed ID: 31658919
[TBL] [Abstract][Full Text] [Related]
14. Neuropsychological differentiation of progressive aphasic disorders.
Harris JM; Saxon JA; Jones M; Snowden JS; Thompson JC
J Neuropsychol; 2019 Jun; 13(2):214-239. PubMed ID: 29424041
[TBL] [Abstract][Full Text] [Related]
15. Utility of the Repeat and Point Test for Subtyping Patients With Primary Progressive Aphasia.
Seckin M; Ricard I; Raiser T; Heitkamp N; Ebert A; Prix C; Levin J; Diehl-Schmid J; Riedl L; Roßmeier C; Hoen N; Schroeter ML; Marschhauser A; Obrig H; Benke T; Kornhuber J; Fliessbach K; Schneider A; Wiltfang J; Jahn H; Fassbender K; Prudlo J; Lauer M; Duning T; Wilke C; Synofzik M; Anderl-Straub S; Semler E; Lombardi J; Landwehrmeyer B; Ludolph A; Otto M; Danek A;
Alzheimer Dis Assoc Disord; 2022 Jan-Mar 01; 36(1):44-51. PubMed ID: 35001030
[TBL] [Abstract][Full Text] [Related]
16. Typical and atypical pathology in primary progressive aphasia variants.
Spinelli EG; Mandelli ML; Miller ZA; Santos-Santos MA; Wilson SM; Agosta F; Grinberg LT; Huang EJ; Trojanowski JQ; Meyer M; Henry ML; Comi G; Rabinovici G; Rosen HJ; Filippi M; Miller BL; Seeley WW; Gorno-Tempini ML
Ann Neurol; 2017 Mar; 81(3):430-443. PubMed ID: 28133816
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal changes in primary progressive aphasias: differences in cognitive and dementia staging measures.
Hsieh S; Hodges JR; Leyton CE; Mioshi E
Dement Geriatr Cogn Disord; 2012; 34(2):135-41. PubMed ID: 23006977
[TBL] [Abstract][Full Text] [Related]
18. Divergent Longitudinal Propagation of White Matter Degradation in Logopenic and Semantic Variants of Primary Progressive Aphasia.
Tu S; Leyton CE; Hodges JR; Piguet O; Hornberger M
J Alzheimers Dis; 2016; 49(3):853-61. PubMed ID: 26484929
[TBL] [Abstract][Full Text] [Related]
19. Progranulin-associated PiB-negative logopenic primary progressive aphasia.
Josephs KA; Duffy JR; Strand EA; Machulda MM; Vemuri P; Senjem ML; Perkerson RB; Baker MC; Lowe V; Jack CR; Rademakers R; Whitwell JL
J Neurol; 2014 Mar; 261(3):604-14. PubMed ID: 24449064
[TBL] [Abstract][Full Text] [Related]
20. Clinical and cortical trajectories in non-fluent primary progressive aphasia and Alzheimer's disease: A role for emotion processing.
Landin-Romero R; Kumfor F; Ys Lee A; Leyton C; Piguet O
Brain Res; 2024 Apr; 1829():148777. PubMed ID: 38286395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
